Dapagliflozin + Metformin

DRUG3 trials

Sponsors

AstraZeneca, Al-Azhar University, Beni-Suef University

Conditions

Healthy Male and Female SubjectsNAFLD (Nonalcoholic Fatty Liver Disease)Type 2 Diabetes

Phase 1

Drug Interaction With Metformin

CompletedNCT00546741

AstraZenecaHealthy Male and Female Subjects

Start: 2007-11-30End: 2008-02-29Updated: 2016-12-20

Phase 4

Effect of Vildagliptin Versus Dapagliflozin as Add on Therapy to Metformin on Cardiovascular Risk Factors

CompletedNCT07077525

Al-Azhar UniversityType 2 Diabetes

Start: 2023-06-01End: 2024-08-31Updated: 2025-07-22

A Study Between Dapagliflozin and Empagliflozin Effect on NAFLD in Patients With Type 2 Diabetes.

CompletedNCT07363707

Beni-Suef UniversityNAFLD (Nonalcoholic Fatty Liver Disease)

Start: 2023-05-01End: 2024-03-01Updated: 2026-02-03